Trials / Completed
CompletedNCT01198782
Evaluating Safety and Efficacy of FID 112903 Post Discontinuation of Long-term Use of RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05%
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of FID 112903 given as an immediate treatment replacement in dry eye subjects that discontinue at least 6 months use of RESTASIS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | FID 112903 (SYSTANE® ULTRA Lubricant Eye Drops) | Patients will dose 4 times daily for 4 months. |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2011-05-01
- Completion
- 2011-05-01
- First posted
- 2010-09-10
- Last updated
- 2016-11-18
Source: ClinicalTrials.gov record NCT01198782. Inclusion in this directory is not an endorsement.